Assertio Therapeutics Inc (ASRT) has released an update.
Assertio Holdings, Inc. is on the verge of being delisted from the Nasdaq Capital Market as its stock price fell below the $1 minimum requirement for 30 days. The company has 180 days, until August 19, 2024, to boost its stock price to $1 for at least 10 consecutive days and avoid delisting. They’re considering measures such as a reverse stock split to regain compliance, but there’s no certainty of success.
For further insights into ASRT stock, check out TipRanks’ Stock Analysis page.
